2,4-disubstituted triazine derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S213010, C544S194000, C544S208000, C544S209000, C544S213000

Reexamination Certificate

active

07015221

ABSTRACT:
This invention concerns the use of the compounds of formulathe N-oxides, the pharmaceutically acceptable addition salts, quaternary amines and the stereochemically isomeric forms thereof, wherein -a1=a2-a3=a4- forms a phenyl, pyridinyl, pyrimidinyl, pyridazinyl or pyrazinyl with the attached vinyl group; n is 0 to 4; and where possible 5; R1is hydrogen, aryl, formyl, C1-6alkylcarbonyl, C1-6alkyl, C1-6alkyloxycarbonyl or substituted C1-6alkyl; each R2independently is hydroxy, halo, optionally substituted C1-6alkyl, C2-6alkenyl or C2-6alkynyl, C3-7cycloalkyl, C1-6alkyloxy, C1-6alkyloxycarbonyl, carboxyl, cyano, nitro, amino, mono- or di(C1-6alkyl)amino, polyhalomethyl, polyhalomethyloxy, polyhalomethylthio, —S(═O)pR4, —NH—S(═O)pR4, —C(═O)R4, —NHC(═O)H, —C(═O)NHNH2, —NHC(═O)R4, —C(═NH)R4or a 5-membered heterocyclic ring; p is 1 or 2; L is optionally substituted C1-10alkyl, C2-10alkenyl, C2-10alkynyl or C3-7cycloalkyl; or L is —X—R3wherein R3is optionally substituted phenyl, pyridinyl, pyrimidinyl, pyrazinyl or pyridazinyl; X is —NR1—, —NH—NH—, —N═N—, —O—, —C(=O)—, —CHOH—, —S—, —S(═O)— or —S(═O)2—; aryl is optionally substituted phenyl; for the manufacture of a medicine for the treatment of subjects suffering from HIV (Human Immunodeficiency Virus) infection.

REFERENCES:
patent: 5017466 (1991-05-01), Kobayashi et al.
patent: 5691364 (1997-11-01), Buckman et al.
patent: 6107301 (2000-08-01), Aldrich et al.
patent: 6200977 (2001-03-01), Cushing et al.
patent: 6342503 (2002-01-01), Aldrich et al.
patent: 6528513 (2003-03-01), Cushing et al.
patent: 6638932 (2003-10-01), De Corte et al.
patent: 6835726 (2004-12-01), Cushing et al.
patent: 2 121 694 (1971-11-01), None
patent: 2226 474 (1973-02-01), None
patent: 0 196 275 (1986-10-01), None
patent: 0 834 507 (1998-04-01), None
patent: 2 099 730 (1972-03-01), None
Ashley, J.N. et al., “The Search for Chemotherapeutic Amidines. Part XVI Amidinoanilino-1,3,5-triazines and Related Compounds”,Journal of the Chemical Society, Jan. 1. 1960, 4525-4531, XP 000573907.
Foye, W.O. et al. “Amine Derivative of cyanuric Chloride. IV. Catalytic Hydrogenolysis of Aromatically-bound Chlorine”,J.Am. Pharm. Assoc., Sci Ed.,1959, 48, 327-329 (Abstract 1 page).
Rajnani, H.B. et al., “Preparation and Hypnotic Activity of 5′-'2, 4-bis(arylamino)-s-triazin-6-yl!barbituric Acids”,J. Inst. Chem.,1978, 50(5), 213-214, XP 002138938.
Burmistrov, S.I. et al., “2,4-Bis(arylamino)-1,3,5,-trazines with Identical Aryl-Amino Groups”,Dzerzhinskii, F.E., Chemical Technlogical Institute,SU 189 438 1 (Abstract 1 page).
Yuki Yasuo, et al., “Preparation of Poly(Amide-Guanamine) and Poly (Pyromellitimide-Guanamine)”,Nippon Kagaku Kaishi, 1977, 4, 549-555(Abstract 1 page).
Yuki Yasuo, et al., “Preparation of Poly(Amide-Guanamine) and Poly(Pyromellitimide)”,Department of Fiber and Polymer, Institute of Technology, Japan,1977, 4, 549-555, (English Abstract 1 page).
Van Der Plas, H.C. et al., “Ring Transformations in Reactions of Heterocyclic Halogeno Compounds with Nucleophiles (XIV)”,Recl. Trav. Chim. Pays-Bas, 1969, 88(4), 426-438.
Yuki, Y. et al., “Synthesis and Properties of Polyguanamines from N,N′-Diphenylguanamines and α, w-Dibromoalkanes”,Polymer Journal, 1996, 28(4), 337-342.
Kobunshi Kagaku,Department of Fiber and Polymer, Nagoya Institute of Technology, Dec. 1973, 30(344), 720-726. English Language abstract for previously submitted publication reference #17.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2,4-disubstituted triazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2,4-disubstituted triazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,4-disubstituted triazine derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3569092

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.